0% found this document useful (0 votes)
45 views6 pages

QC in Viral Vaccine and Vector Production Brochure en L Data

The document discusses the growing importance of quality control (QC) in the production of viral vaccines and viral vectors, highlighting the shift towards recombinant viral vectors and virus-like particles. It outlines various QC applications throughout the production process, from raw material testing to final product release, emphasizing the need for safety, effectiveness, and purity. Additionally, it presents Sartorius solutions that aid in overcoming quality control challenges in viral vaccine production.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
45 views6 pages

QC in Viral Vaccine and Vector Production Brochure en L Data

The document discusses the growing importance of quality control (QC) in the production of viral vaccines and viral vectors, highlighting the shift towards recombinant viral vectors and virus-like particles. It outlines various QC applications throughout the production process, from raw material testing to final product release, emphasizing the need for safety, effectiveness, and purity. Additionally, it presents Sartorius solutions that aid in overcoming quality control challenges in viral vaccine production.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 6

Quality Control

of Viral Vaccine
and Viral Vector
Production
Growing in
Importance
While inactivated or live attenuated vaccines dominate Quality Control of the Viral Vaccine
the market today, a new generation of viral vaccines
known as recombinant viral vectors or virus-like-par- and Viral Vector Production
ticles (VLPs) are in the pre-clinical and clinical devel-
opment phases. Viral vectors are also widely used for Process — Ensuring That Your
gene therapy and oncolytic applications.
Product Is Safe, Effective, and Pure.

Take a look at the example production process map,


with the most important QC applications, and see
where our products and services can help you over-
come some of your quality control challenges from
master viral seed (MVS) and master cell bank (MCB)
all the way to final product release testing.

Raw material testing In-process control Final release

Find out more


For more information, please visit
sartorius.com
Sartorius QC Solutions Upstream Process

9 Biosafety and Characterization 3 Mycoplasma Testing


3 Mycoplasma Testing 4 Bioburden
5 Virus Analytics
9 Biosafety, Replication
l m n Competence and
Unprocessed Characterization
Cell Bank Virus Seed
Bulk Harvest

a b Optional: c
Microcarrier
Seed Expansion Virus Propagation Removal; Cell Removal Bulk Harvest
Cell Lysis

1 Viability and Cell Count 1 Viability and Cell Count 5 Virus Analytics
2 Metabolites Measuring 2 Metabolites Measuring
4 Bioburden
5 Virus Analytics

k
Media Preparation Medium, Feeds

9 Biosafety and Characterization


3 Mycoplasma Testing
4 Bioburden
Typically performed by the vendor
Your Application

1 2 3
Viability and Cell Count Metabolite Measurement Mycoplasma Detection
Gives information about viable cell Gives information about the pro- Detect mycoplasma within three hours.
density in your cell culture; Allows ductivity, biochemical status, and
automated cell bleed for perfusion lifecycle of your cells; Allows auto- Process Steps: k l m n o p q
processes or inoculation of seed mated feed control based on glu-
trains. cose measurements.

Process Steps: a b Process Steps: a b


Sartorius Solutions

In-line monitoring and control of On-line monitoring and control Microsart® Mycoplasma AMP qPCR kit —
viable biomass in cell culture pro- of glucose and lactate with a rapid, reliable, and easy-to-use solution in
cesses with BioPAT® ViaMass BioPAT® Trace compliance with international guidelines

Fully automated control of the cultivation process Reduce time-to-result significantly


Downstream Process

5 Virus Analytics
4 Bioburden

d e Inactivation f g h
(optional Buffer
Clarification Concentration by vaccine Capture Polishing
Exchange
production)

o
Buffer Preparation Buffer

9 Biosafety and Characterization


3 Mycoplasma Testing
4 Bioburden
Typically performed by the vendor

4 5 6
Microbial Contamination Virus Analytics Sterility Testing
Control | Bioburden Testing Real-time tracking of virus titer Proof of sterility by membrane filtration method
Count the number of microbes in during growth, harvest, purifica- or rapid testing.
your sample using touch-free tion, and release allows process
membrane transfer to agar. optimization and early detection Process Steps: j
of problems.
Process Steps: b d e f
Process Steps: b c d e
g h i k n o p q
f g h i j n p q

Microsart @filter and @media Virus Counter® 3100 Platform Batch release sterility testing with Rapid sterility testing
membrane filtration method for rapidly and precisely quantifies the Sterisart® NF canisters and based on qPCR
forceps-free and effortless total virus particles, providing Universal pump in compliance
membrane transfer results in minutes with international pharmacopeia

Minimize risk of Quantify a wide range Easy handling and reliable Know results in just 3
 hours
cross-contamination of viruses and VLPs test results
Fill and Finish
9 Biosafety
3 Mycoplasma Testing
4 Bioburden

p
Buffer Preparation Buffer

i j

Sterile
Drug Substance Formulation Filling Drug Product
Filtration

4 Bioburden q 6 Sterility
5 Virus Analytics 5 Virus Analytics
9 Biosafety and Excipient Preparation Excipients 9 Biosafety and
Characterization Characterization
Product and process related Product and process related
impurities, product purity impurities, product purity
Potency, identity, quantity 9 Biosafety and Characterization Potency, identity, quantity
Advanced physico-chemical 3 Mycoplasma Testing Advanced physico-chemical  
characterization 4 Bioburden* characterization
* depending on the nature of the excipient

7 8 9
Microbial Air Monitoring Data Analytics Biosafety and Characterization Testing Service
Quantitative detection of airborne Analysis and interpretation of Sartorius Cell Line and Media Testing Solutions (CL&MTS) is a
microorganism. complex data. leading Contract Testing and Research Organization specializing
in biosafety, biological activity, physico-chemical and structural
Process Steps: specified rooms, Process Steps: throughout the analyses.
clean rooms and filling lines manufacturing process
Process Steps: i j k l m n o p q

Active air monitoring with MD8 Analyze and interpret complex Endotoxin:
Airscan®—agar-free, continuous data to efficiently develop new Chromogenic LAL test, compliant to USP and EP requirements
air monitoring products, and control quality and
Virus testing:
costs
Endogenous viral particles, adventitious virus, retrovirus assays,
virus and vector shedding

Product Impurities:
UPLC assays, SEC for aggregates stability studies
Process Impurities:
Residual Host Cell Proteins by ELISA, Residual DNA by qPCR

Ensure the most accurate Identify efficiently critical Release your final product safer and more
data over an 8 hour period process parameters cost-effectively
Planning for Quality Control Testing: Sample and Buffer Preparation
Contamination costs time and money. Improve the reliability of your analytical results and ensure speed-to-market
by investing in appropriate contamination prevention products.

Sampling and Aseptic Fluid Transfer Clarification and Filtration Concentration and Purification of
TAKEONE® Aseptic Sampling System, Sartoclear Dynamics® Lab V50 kits: Viruses
MYCAP® Bottle Closures, and QUICK- Virus harvesting in one step. Kits com- Vivapure® Virus Purification and Con-
SEAL® Aseptic Disconnect bine a vacuum filtration unit, Sartolab® centration Kits. Adenovirus Purification
RF 50 with a 0.45 µm PES membrane, with AdenoPACK kits and Lentivirus
and a filter aid for clarification. Purification with LentiSELECT kits

Pharma Compliant Weighing


Cubis® II Premium Lab Balances. Sartorius’s Cubis® II is designed to follow
US FDA data integrity principles that require data to be accurate, legible,
contemporaneous, original, and attributable (ALCOA). The Cubis® II balance,
with pharma package, contains all the technical controls to support full compli-
ance with common regulations.

See more Sample Preparation Solutions!


sartorius.com/en/applications/quality-control-testing/sample-preparation-qc

Service and Training


A comprehensive offering that includes qualified personnel, ensuring high-quality results and optimal operation.

Sales and Service Germany USA


Sartorius Lab Instruments Sartorius Corporation
Contacts GmbH & Co. KG 565 Johnson Avenue
Otto-Brenner-Strasse 20 Bohemia, NY 11716
For further contacts, visit 37079 Goettingen Phone +1 631 254 4249
sartorius.com Phone +49 551 308 0 Toll-free +1 800 635 2906

© 2020. Specifications subject to change without notice.


Copyright Sartorius Lab Instruments GmbH & Co. KG.
Printed in the EU or US on paper bleached without chlorine.
Version 1 | 2020 | 02

You might also like